MBBS (Hons), FCICM, FRACP, PGDipEcho Claire is a senior intensive care specialist, and became Director of ICU in 2020. Originally from Tasmania, Claire completed her medical degree in Hobart in 1999. After training at both The Alfred and Barwon Health, Claire began work as a Specialist in Barwon Health ICU in 2009. Major clinical projects include developing the Paediatric ICU program in University Hospital Geelong. Her work in this area was a significant factor in UHG being awarded the Victorian Premier’s Health Care Secretary Award for Improving Patient Outcomes and Patient Experience in 2014. Claire has a strong interest in education, having involvement with Deakin University, and ICU Supervisor of Training. Claire is also involved in Quality and Safety activities and is current Chair of the Blood and Blood Products Committee.
Clinical leadership
Claire became Director of Intensive Care at University Hospital Geelong in 2020. She has undertaken the Harvard Emerging Women Executives in Health Care Program, and is Chair of the Barwon Health Blood and Blood Products Committee, and led the development of the Barwon Health Paediatric Critical Care Program from 2011-2018.
Latest news:
-
Tuesday, June 29, 2021 - 17:07
NEJM TTM2: hypothermia (33C for 28 hrs then avoid >37.8C to 72 hrs) vs normothermia ( <37.8C), after OHCA + coma = no difference death and poor functional outcome at 6 months. In general TTM1 and 2 report no difference between 33, 36, and 37.8C.
Saturday, May 29, 2021 - 17:55JAMA COBI RCT continuous infusion 20% hypertonic saline vs standard care for minimum 48 hours in moderate to severe TBI = no difference neurological outcome 6 months. Intervention associated lower risk intracranial hypertension for 1st 2-days, followed by rebound ICH, apparent after cessation of therapy.
Wednesday, May 12, 2021 - 17:20JAMA MIS-C - Observational study of combined treatment with IVIG + methylprednisolone vs IVIG alone associated with reduced treatment failure, new LV dysfunction, hemodynamic support, and PICU LOS better course of fever in children with MIS-C.
Tuesday, May 11, 2021 - 14:37JAMA REALITY - Restrictive transfusion strategy compared with a liberal strategy resulted in a noninferior rate of major cardiovascular events among patients with acute myocardial infarction and anemia.
Monday, May 10, 2021 - 19:06NEJM CONFIRM terlipressin with albumin more effective than albumin alone at reversing hepatorenal syndrome in adults with cirrhosis and HRS-1. Interesting cautionary discussion about terlipressin association with more serious adverse events, particularly respiratory failure..